Clinical Trial Update: Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix [Phase 3]

View source ↗

Summary

Phase 3 trial update on AV2 antiviral drug for HPV-associated cervical lesions showing completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillomavirus Infections
• Uterine Cervical Dysplasia

Drugs mentioned

• AV2 antiviral drug

Snippet

Sponsor: Jean-Pierre Van geertruyden | Conditions: Uterine Cervical Dysplasia, Papillomavirus Infections | Phase 3 | Status: COMPLETED